Loading…
← CockpitCompetitor Analysis › 6993.HK Blue Moon Group Holdings Ltd.Open in the cockpit ↗

Blue Moon Group Holdings Ltd.6993.HKCompetitor analysis, valuation and peers

Hong Kong · HKD·Consumer Staples›Household/Personal Care

Chinese maker of laundry detergent, fabric softener and household cleaning products under the Blue Moon brand.

≈ China's Procter & Gamble for laundry/home careMomentum strong 73
Mkt cap
$2.07B
US dollars, full cap
Free float
20%
of shares outstanding
$/day
$219,508
20-day average traded
Fwd P/E
103.3×
forward earnings
ROIC−WACC
-11.3 pp
WACC 7.9%
Hurdle
n/a
no reverse DCF
Next earnings
132 days
30 Mar 2027
Close · HKDHK$2.89
1D-0.2%
1W+3.8%
1M+11.6%
3M-11.3%
6M-4.3%
YTD+7.4%
1Y-1.0%
ATR %3.1%
52w lowhigh27.3% off high

What Blue Moon does

Chinese maker of laundry detergent, fabric softener and household cleaning products under the Blue Moon brand.

Sells mass-market home-care products through supermarkets and online platforms, with liquid laundry products the main line and fabric care and hand-washing products added around it. Founder Luo Qiuping controls the company, and sales are mainly in mainland China.

In one line: China's Procter & Gamble for laundry/home care.

Products and services

  • Laundry detergent
  • Fabric softener
  • Hand/dish soap
  • Household cleaning products

Customers

  • Chinese retail consumers via supermarkets and e-co

Where it sits in the supply chain

  • Consumer Staples
  • Household care
  • Laundry & cleaning products

What could go right

  • Premiumization of home-care products in China

What could go wrong

  • Intense e-commerce price competition
  • Raw-material cost swings

Moat: narrow (brand, distribution). Leading, widely trusted household-cleaning brand in China with strong e-commerce distribution.

Headquarters: Guangzhou, China · Founded: 1992 · Employees: 6,514

Named competitors

Blue Moon at a glance

Size Blue Moon (6993.HK) is a Hong Kong Consumer Staples company (Household/Personal Care) with a market value of $2.07B, the 401st largest of 885 Hong Kong companies the cockpit tracks. Shares closed at HK$2.89 on 18 Nov 2026.

Performance Over six months the shares fell 4.3%, against -1.6% for the median peer and -14.0% for the Hong Kong market (cap-weighted) — 11th highest of 21 in its peer set.

Growth Revenue fell 2.4% over the last twelve months (peer median +5.6%); the operating margin is -2.0% (peer median 10.6%).

Valuation It trades at 103.3× forward earnings against a peer median of 19.5× (most expensive of 21).

Capital Return on invested capital runs 11.3 points below its cost of capital (7.9% WACC).

Next results Next results expected around 30 Mar 2027 (exchange calendar; dates can move).

Relative performance

8010012021 May 202621 Aug 202618 Nov 2026Peer median 1016993.HK 98
Six months, rebased to 100: Blue Moon against the median of its 20 peers (local-currency closes).

Blue Moon financials

Reported figures in HKD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueHK$8.25BHK$8.41BHK$8.56BHK$7.32BHK$7.95B
Revenue growth—-2%+17%-8%—
Gross profitHK$4.75BHK$4.88BHK$5.02BHK$4.36BHK$4.41B
EBITDAHK$59.1M-HK$206M-HK$740MHK$351MHK$1.02B
Net income-HK$86.1M-HK$329M-HK$749MHK$325MHK$611M
Free cash flow-HK$198M-HK$543M-HK$1.03BHK$657MHK$266M
Capital expenditureHK$348MHK$191MHK$150MHK$92.6MHK$289M
Total debtn/aHK$84.9MHK$99.7MHK$159MHK$200M

Quarterly statements and history in the cockpit →

Blue Moon competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%0%+20%+40%-10%0%+10%161890492749222698EMAMILTDENRPGHH79562367192820300888GILLETTE300957603983600315002790051900301371603605ICOS6993.HK6-month return →1-month return →
Up and to the right = strong over both horizons. Blue Moon is the large dot.

Fundamentals: revenue growth against valuation

0%+10%+20%25×50×75×100×161890492749222698EMAMILTDENRPGHH79562367192820300888GILLETTE300957603983600315002790051900603605ICOS6993.HKRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Blue Moon is the large dot.

Blue Moon competitors and peer comparison

Head to head with its named competitors (6993.HK vs PG vs ULVR.L)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Blue Moon 6993.HK$2.07B-4%-2%-2%103.3×n/a
Procter & Gamble PG$395B+20%+4%24%24.1×0.5%
Unilever ULVR.L$139B+15%-20%20%18.2×8.1%

How Blue Moon compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Blue Moon against its 20 peers (data as of 18 Nov 2026)
Measure6993.HKPeer medianRank in peer set
1-month return+11.6%+0.9%2nd highest of 21
6-month return-4.3%-1.6%11th highest of 21
Distance from 52-week high-27.3%-24.8%9th lowest of 21
Revenue growth (TTM)-2.4%+5.6%5th lowest of 21
Operating margin-2.0%10.6%lowest of 21
Forward P/E103.3×19.5×most expensive of 21
ROIC minus cost of capital-11.3 pp+5.4 pplowest of 20
Net debt / EBITDA-46.7×-1.1×least indebted of 15

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Blue Moon 6993.HKHong Kong$2.07B-4%-2%-2%103.3×n/an/a
Kolmar Korea 161890.KSSouth Korea$2.05B+14%+16%10%14.3×-1.6%+15.5%
Pola Orbis 4927.TJapan$2.04B+15%+1%11%30.6×-2.0%-0.7%
KOSE 4922.TJapan$2.16B+16%+4%5%29.9×n/an/a
Softcare 2698.HKHong Kong$2.20B+5%+25%25%14.4×9.1%+20.9%
Emami EMAMILTD.NSIndia$1.94B-5%+13%20%23.4×21.5%+5.6%
Energizer ENRUnited States$1.94B+71%0%17%9.1×-5.1%-0.5%
Procter & Gamble Hygiene & Health Care PGHH.NSIndia$2.37B-30%-2%24%27.0×21.2%+7.4%
Pigeon 7956.TJapan$1.76B+26%+8%13%27.9×-2.4%+1.9%
Giant Biogene 2367.HKHong Kong$2.47B-32%-10%32%8.6×-10.7%+34.9%
Cosmax 192820.KSSouth Korea$2.51B+53%+25%8%18.8×n/an/a
Winner Medical 300888.SZChina$2.53B-6%+4%11%19.9×-5.2%-2.6%
Gillette India GILLETTE.NSIndia$2.53B-5%+8%28%37.1×14.9%+13.0%
Yunnan Botanee Bio-Technology 300957.SZChina$1.69B-33%+7%9%19.1×2.6%+15.3%
Guangdong Marubi Biotechnology 603983.SSChina$1.62B+9%-6%2%45.5×n/an/a
Shanghai Jahwa United 600315.SSChina$1.61B-15%+9%2%15.4×15.3%-2.1%
AMOREPACIFIC 002790.KSSouth Korea$1.61B+2%+9%9%8.5×-5.7%-1.3%
LG H&h 051900.KSSouth Korea$2.81B-14%-3%3%23.1×-4.6%-4.1%
Harbin Fuerjia Technology 301371.SZChina$1.51B-39%+28%20%21.4×7.5%+3.6%
Proya Cosmetics 603605.SSChina$2.87B-13%+2%13%10.9×-5.3%+23.1%
Intercos ICOS.MIItaly$1.43B+12%-5%9%18.9×4.3%+11.5%

Questions

Who are Blue Moon's main competitors?
Named competitors: Procter & Gamble (PG), Unilever (ULVR.L). The cockpit's measured peer set (industry) also includes Kolmar Korea (161890.KS), Pola Orbis (4927.T), KOSE (4922.T), Softcare (2698.HK), Emami (EMAMILTD.NS), Energizer (ENR).
Is Blue Moon expensive compared with its peers?
On forward p/e it trades at 103.3× against a peer median of 19.5×, most expensive of 21 in its peer set.
How has Blue Moon stock performed?
Over six months to 18 Nov 2026 the shares returned -4.3% against -1.6% for the median peer; over one year -1.0%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.